Evaluation of brachytherapy and external beam radiation therapy for early stage, node-negative uterine carcinosarcoma

For patients with Stages I-II UCS, adjuvant radiotherapy type did not influence survival after hysterectomy. This study addresses an existing evidence gap and identifies a trend toward increasing utilization of BT alone. Prospective trials are warranted to provide high-quality evidence to guide adjuvant therapy decisions for these patients.